Group 6 Copy 130
-7
Please wait...

About This Project

OncoSynergy, Inc.
The Ebola outbreak in west Africa has been declared a global emergency by the WHO with over 1,000 victims and no approved therapies. OncoSynergy is developing a readily manufactured experimental cancer drug, OS2966, which coincidentally targets the receptor hijacked by ebola to infect cells. This project aims to demonstrate that OS2966 inhibits ebola infection of human cells thus providing the impetus for expediting OS2966 for treatment of ebola.
Blast off!

Browse Other Projects on Experiment

Related Projects

How do post-industrial landscapes affect American Woodcock breeding success?

I study American Woodcock breeding success in post-industrial habitat to see if human altered habitat can...

E pluribus unum: how honey bee bacteria coordinate behaviors

The honey bee is a charismatic species that plays a critical role in the pollination of agriculturally important...

Are biofilms responsible for heavy metals on plastic debris?

I want to know how ocean bacteria and algae that live on plastic debris influence the toxins plastic picks...

Backer Badge Funded

A biology project funded by 47 people